ZA87149B - Pharmaceutical compositions containing peptides of the cholecystokinin-cerulein group for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies - Google Patents

Pharmaceutical compositions containing peptides of the cholecystokinin-cerulein group for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies

Info

Publication number
ZA87149B
ZA87149B ZA87149A ZA87149A ZA87149B ZA 87149 B ZA87149 B ZA 87149B ZA 87149 A ZA87149 A ZA 87149A ZA 87149 A ZA87149 A ZA 87149A ZA 87149 B ZA87149 B ZA 87149B
Authority
ZA
South Africa
Prior art keywords
cholecystokinin
respiratory
pharmaceutical compositions
compositions containing
therapy
Prior art date
Application number
ZA87149A
Other languages
English (en)
Inventor
Alfio Bertolini
Original Assignee
Alfio Bertolini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfio Bertolini filed Critical Alfio Bertolini
Publication of ZA87149B publication Critical patent/ZA87149B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA87149A 1986-01-10 1987-01-09 Pharmaceutical compositions containing peptides of the cholecystokinin-cerulein group for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies ZA87149B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19055/86A IT1204430B (it) 1986-01-10 1986-01-10 Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria

Publications (1)

Publication Number Publication Date
ZA87149B true ZA87149B (en) 1987-09-30

Family

ID=11154164

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA87149A ZA87149B (en) 1986-01-10 1987-01-09 Pharmaceutical compositions containing peptides of the cholecystokinin-cerulein group for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies

Country Status (8)

Country Link
US (1) US4794103A (fr)
EP (1) EP0239716B1 (fr)
JP (1) JP2534998B2 (fr)
AT (1) ATE87485T1 (fr)
DE (1) DE3785066T2 (fr)
ES (1) ES2053454T3 (fr)
IT (1) IT1204430B (fr)
ZA (1) ZA87149B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1218472B (it) * 1985-08-30 1990-04-19 Alfio Bertolini Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
SE8901149D0 (sv) * 1989-04-03 1989-04-03 Pharmacia Ab Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
EP0522596A1 (fr) * 1989-04-03 1993-01-13 Kabi Pharmacia AB Procédé et moyen pour induire la constriction de la pupille de l'oeil
JPH08500577A (ja) * 1992-07-15 1996-01-23 ユニヴァーシティ オブ サウス フロリダ パニック障害の治療に関連するｃｃｋペプチドの血中濃度
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
US20040001842A1 (en) * 1997-05-12 2004-01-01 Dov Michaeli Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
ATE361098T1 (de) * 1998-05-15 2007-05-15 Receptor Biologix Inc Vorbeugung und behandlung von hypergastrinemie
JP2003522105A (ja) * 1998-06-18 2003-07-22 チョワース、ミッチャル、ワイ． ヘリコバクター・ピロリ（Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ）関連疾患治療用医薬組成物
SE9901578D0 (sv) * 1999-05-03 1999-05-03 Karolinska Innovations Ab New use of substance in PNS
CA2441228A1 (fr) 2001-03-23 2002-10-03 Aphton Corporation Traitement combine du cancer du pancreas
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
US6810583B2 (en) * 2001-08-07 2004-11-02 International Business Machines Corporation Coupling of conductive vias to complex power-signal substructures
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
JP4689597B2 (ja) * 2003-03-28 2011-05-25 レセプター バイオロジックス インク． ガストリンホルモン免疫アッセイ
CA2580965C (fr) 2004-09-22 2014-04-08 Receptor Biologix, Inc. Anticorps monoclonaux de progastrine
US20080077949A1 (en) * 2006-09-22 2008-03-27 Inventec Corporation Rotating data storage device anti-shake mechanism
JP7469225B2 (ja) 2017-06-15 2024-04-16 キャンサー アドヴァンシーズ インク． 腫瘍及び癌に対する体液性及び細胞性免疫を誘発するための組成物及び方法
RU2667466C1 (ru) * 2017-11-27 2018-09-19 Общество с ограниченной ответственностью "МЕДИНВЕСТ" Пептидное соединение, восстанавливающее функцию органов дыхания и обладающее иммуномодулирующим действием

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723406A (en) * 1969-12-23 1973-03-27 Squibb & Sons Inc Novel peptides having cholecystokinin activity and intermediates therefor
DE2256445C3 (de) * 1972-11-17 1981-11-05 Hoechst Ag, 6000 Frankfurt Heptapeptide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE3138233A1 (de) * 1981-09-25 1983-04-07 Farmitalia Carlo Erba S.p.A., 20159 Milano Neuropsychotropisches arzneimittel

Also Published As

Publication number Publication date
JP2534998B2 (ja) 1996-09-18
ATE87485T1 (de) 1993-04-15
EP0239716B1 (fr) 1993-03-31
EP0239716A3 (en) 1990-05-23
DE3785066T2 (de) 1993-07-08
DE3785066D1 (de) 1993-05-06
EP0239716A2 (fr) 1987-10-07
IT1204430B (it) 1989-03-01
IT8619055A0 (it) 1986-01-10
JPS62246521A (ja) 1987-10-27
ES2053454T3 (es) 1994-08-01
US4794103A (en) 1988-12-27

Similar Documents

Publication Publication Date Title
EP0239716A3 (en) Pharmaceutical compositions containing peptides of the cholecystokinin-cerulein group for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies
IL107004A0 (en) (s)-(+)-hydroxychloroquine and pharmaceutical compositions containing it
IL83363A (en) Use of indol-3-yl-carboxylic acid endo-8-methyl-8-aza- bicyclo (3,2,1) oct-3-yl ester for the preparation of psycho-active pharmaceutical compositions suitable for the treatment of stress- related psychiatric disorders or for increasing vigilance
PT82580A (en) Therapeutic nucleosides
GR3007251T3 (fr)
GR3031448T3 (en) Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine.
PT80079A (en) Process for the preparation of antiviral pharmaceutical preparations containing 2-diethylamino-2,2',6'-acetoxyxylidide (lidocaine)
IL105724A0 (en) Purified forms of dnase
NO921829L (no) Nytt polypeptid, samt anti-hiv-medikament fremstilt derav
ZA866287B (en) Pharmaceutical compositions containing acth(1-24)for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies
GR3006999T3 (fr)
IL84550A (en) Pharmaceutical compositions for treatment of viral infections containing 3( -fluoro-3(-deoxy-thymidine
IT8619086A0 (it) Composizioni farmaceutiche comprendenti frammenti di acth per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria.
EP0271447A3 (en) Preventive measures for preventing the "bovine complex respiratory disease" by administering interferon
IL94402A0 (en) Pharmaceutical compositions containing imidazodiazepines for the treatment of neurological symptoms
DK1707568T3 (da) Farmaceutisk sammensætning til anvendelse i behandlingen af ovariecancer hos et menneske, der har sygdommen
HU9501627D0 (en) Compositions containing acyclovir-like compounds and 2`-vinyl substituted nucleoside analogs for the treatment of viral infections
EP0356900A3 (en) Use of drugs containing interferon-gamma for treatment and prevention of primary immunodeficiency